← FDA Drug Approvals (Drugs@FDA)

CYCLOSPORINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2026-01-21

Drug application

FDA Application #

ANDA209064

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYCLOSPORINE

Generic name

CYCLOSPORINE

Active ingredients

CYCLOSPORINE

Dosage form

EMULSION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

TWI PHARMS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2026-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown